MedPath

北京亚东生物制药(安国)有限公司

Ownership
-
Established
2004-06-15
Employees
-
Market Cap
-
Website
bjyadong.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

19

NMPA:19

Drug Approvals

Chloramphenicol Eye Drops

Product Name
氯霉素滴眼液
Approval Number
国药准字H11021442
Approval Date
May 10, 2024
NMPA

Ribavirin Eye Drops

Product Name
利巴韦林滴眼液
Approval Number
国药准字H11021626
Approval Date
May 10, 2024
NMPA

Taurine Eye Drops

Product Name
牛磺酸滴眼液
Approval Number
国药准字H11022225
Approval Date
May 10, 2024
NMPA

Moroxydine Hydrochloride Eye Drops

Product Name
盐酸吗啉胍滴眼液
Approval Number
国药准字H11021937
Approval Date
May 10, 2024
NMPA

Compound Zinc Sulfate Eye Drops

Product Name
复方硫酸锌滴眼液
Approval Number
国药准字H11022356
Approval Date
May 10, 2024
NMPA

Idoxuridine Eye Drops

Product Name
碘苷滴眼液
Approval Number
国药准字H11021336
Approval Date
May 10, 2024
NMPA

Phacolysin Eye Drops

Product Name
法可林滴眼液
Approval Number
国药准字H11022146
Approval Date
May 10, 2024
NMPA

北芪精

Approval Number
国药准字H11022450
Approval Date
Jul 28, 2023
NMPA

颈康胶囊

Approval Number
国药准字Z20080509
Approval Date
Aug 20, 2021
NMPA

Recombinant Human Insulin

Product Name
人胰岛素
Approval Number
国药准字S20020038
Approval Date
Feb 9, 2021
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.